Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Advances in the treatment of nonalcoholic fatty liver disease.

Mehta SR.

Ther Adv Endocrinol Metab. 2010 Jun;1(3):101-15. doi: 10.1177/2042018810379587.

2.

Nonalcoholic fatty liver disease: from pathogenesis to patient care.

Perlemuter G, Bigorgne A, Cassard-Doulcier AM, Naveau S.

Nat Clin Pract Endocrinol Metab. 2007 Jun;3(6):458-69. Review.

PMID:
17515890
3.

Therapy of nonalcoholic fatty liver disease: current status.

Duvnjak M, Tomasic V, Gomercic M, Smircic Duvnjak L, Barsic N, Lerotic I.

J Physiol Pharmacol. 2009 Dec;60 Suppl 7:57-66. Review.

4.

Nonalcoholic fatty liver disease.

Hjelkrem MC, Torres DM, Harrison SA.

Minerva Med. 2008 Dec;99(6):583-93. Review.

PMID:
19034256
5.

Treatment of Nonalcoholic Fatty Liver Disease.

Liangpunsakul S, Chalasani N.

Curr Treat Options Gastroenterol. 2003 Dec;6(6):455-463.

PMID:
14585234
6.

[Therapeutic options for nonalcoholic fatty liver disease and steatohepatitis].

Kluwe J, Lohse AW.

Internist (Berl). 2005 Dec;46(12):1324-30. Review. German.

PMID:
16247633
7.

Nonalcoholic steatohepatitis and the cardiometabolic syndrome.

Abdeen MB, Chowdhury NA, Hayden MR, Ibdah JA.

J Cardiometab Syndr. 2006 Winter;1(1):36-40.

8.

[Steatosis and steatohepatitis in diabetic patient].

Hůlek P, Dresslerová I.

Vnitr Lek. 2011 Apr;57(4):364-7. Review. Czech.

PMID:
21612059
9.

Nonalcoholic fatty liver disease.

Adams LA, Lindor KD.

Ann Epidemiol. 2007 Nov;17(11):863-9. Epub 2007 Aug 28. Review.

PMID:
17728149
10.

Nonalcoholic fatty liver disease in India - a lot done, yet more required!

Duseja A.

Indian J Gastroenterol. 2010 Nov;29(6):217-25. doi: 10.1007/s12664-010-0069-1. Epub 2010 Dec 30. Review.

PMID:
21191681
11.

Current treatment strategies for non-alcoholic fatty liver disease (NAFLD).

Mishra P, Younossi ZM.

Curr Drug Discov Technol. 2007 Aug;4(2):133-40.

PMID:
17691915
12.

Weight loss: cornerstone in the treatment of non-alcoholic fatty liver disease.

Tilg H, Moschen A.

Minerva Gastroenterol Dietol. 2010 Jun;56(2):159-67. Review.

PMID:
20485253
13.

Nonalcoholic fatty liver disease/steatohepatitis: epidemiology, pathogenesis, clinical presentation and treatment.

Milić S, Stimac D.

Dig Dis. 2012;30(2):158-62. doi: 10.1159/000336669. Epub 2012 Jun 20. Review.

PMID:
22722431
14.

Nonalcoholic fatty liver disease and the metabolic syndrome.

Marchesini G, Babini M.

Minerva Cardioangiol. 2006 Apr;54(2):229-39. Review.

PMID:
16778754
15.

Nonalcoholic Fatty Liver Disease (NAFLD): Approach in the Adolescent Patient.

Roberts EA, Yap J.

Curr Treat Options Gastroenterol. 2006 Sep;9(5):423-31.

PMID:
16942668
16.

Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations.

Preiss D, Sattar N.

Clin Sci (Lond). 2008 Sep;115(5):141-50. doi: 10.1042/CS20070402. Review.

PMID:
18662168
17.

Nonalcoholic fatty liver disease.

Angulo P.

Rev Gastroenterol Mex. 2005 Nov;70 Suppl 3:52-6. Review.

PMID:
17471859
18.

Lipid-lowering agents in nonalcoholic fatty liver disease and steatohepatitis: human studies.

Nseir W, Mograbi J, Ghali M.

Dig Dis Sci. 2012 Jul;57(7):1773-81. doi: 10.1007/s10620-012-2118-3. Epub 2012 Mar 15. Review.

PMID:
22419057
19.

[Non-alcoholic fatty liver disease--new view].

Raszeja-Wyszomirska J, Lawniczak M, Marlicz W, Miezyńska-Kurtycz J, Milkiewicz P.

Pol Merkur Lekarski. 2008 Jun;24(144):568-71. Review. Polish.

PMID:
18702346
20.

Advances in the understanding and treatment of nonalcoholic fatty liver disease.

Harrison SA, Di Bisceglie AM.

Drugs. 2003;63(22):2379-94. Review.

PMID:
14609346

Supplemental Content

Support Center